Global Alpha Synuclein Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Alpha Synuclein Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Alpha Synuclein report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Alpha Synuclein market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Multiple System Atrophy and Neurodegenerateive Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Alpha Synuclein industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Alpha Synuclein key manufacturers include AC Immune SA, AFFiRiS AG, BioArctic AB, Biogen Inc, Evotec AG, Genmab A/S, H. Lundbeck A/S, ICB International Inc and MedImmune LLC, etc. AC Immune SA, AFFiRiS AG, BioArctic AB are top 3 players and held % sales share in total in 2022.
Alpha Synuclein can be divided into AV-1950R, AV-1947D, BAN-0805 and BIIB-054, etc. AV-1950R is the mainstream product in the market, accounting for % sales share globally in 2022.
Alpha Synuclein is widely used in various fields, such as Multiple System Atrophy, Neurodegenerateive Disease, Lewy Body Dementia and Others, etc. Multiple System Atrophy provides greatest supports to the Alpha Synuclein industry development. In 2022, global % sales of Alpha Synuclein went into Multiple System Atrophy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Alpha Synuclein market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AC Immune SA
AFFiRiS AG
BioArctic AB
Biogen Inc
Evotec AG
Genmab A/S
H. Lundbeck A/S
ICB International Inc
MedImmune LLC
Neuropore Therapies Inc
nLife Therapeutics SL
Prothena Corp Plc
QR Pharma Inc
reMYND NV
Segment by Type
AV-1950R
AV-1947D
BAN-0805
BIIB-054
DPC-003
Others
Multiple System Atrophy
Neurodegenerateive Disease
Lewy Body Dementia
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Alpha Synuclein market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Alpha Synuclein, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Alpha Synuclein industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Alpha Synuclein in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Alpha Synuclein introduction, etc. Alpha Synuclein Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Alpha Synuclein market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Alpha Synuclein industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Alpha Synuclein key manufacturers include AC Immune SA, AFFiRiS AG, BioArctic AB, Biogen Inc, Evotec AG, Genmab A/S, H. Lundbeck A/S, ICB International Inc and MedImmune LLC, etc. AC Immune SA, AFFiRiS AG, BioArctic AB are top 3 players and held % sales share in total in 2022.
Alpha Synuclein can be divided into AV-1950R, AV-1947D, BAN-0805 and BIIB-054, etc. AV-1950R is the mainstream product in the market, accounting for % sales share globally in 2022.
Alpha Synuclein is widely used in various fields, such as Multiple System Atrophy, Neurodegenerateive Disease, Lewy Body Dementia and Others, etc. Multiple System Atrophy provides greatest supports to the Alpha Synuclein industry development. In 2022, global % sales of Alpha Synuclein went into Multiple System Atrophy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Alpha Synuclein market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AC Immune SA
AFFiRiS AG
BioArctic AB
Biogen Inc
Evotec AG
Genmab A/S
H. Lundbeck A/S
ICB International Inc
MedImmune LLC
Neuropore Therapies Inc
nLife Therapeutics SL
Prothena Corp Plc
QR Pharma Inc
reMYND NV
Segment by Type
AV-1950R
AV-1947D
BAN-0805
BIIB-054
DPC-003
Others
Segment by Application
Multiple System Atrophy
Neurodegenerateive Disease
Lewy Body Dementia
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Alpha Synuclein market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Alpha Synuclein, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Alpha Synuclein industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Alpha Synuclein in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Alpha Synuclein introduction, etc. Alpha Synuclein Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Alpha Synuclein market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.